NCT01130961已完成不适用
Management of Advanced Non-Small Cell Lung Cancer and Clinical Outcomes in Patients Who Received Gefitinib (IRESSA) in Tertiary Care Setting in Thailand
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 104
- 试验地点
- 1
- 主要终点
- Progression-free survival
研究概览
简要总结
The purpose of this study is to determine progression-free survival of lung cancer patients who received gefitinib in clinical practice in Thailand.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed as having lung cancer based on histological/cytological findings
- •Admitted to the hospital between January 2004 and December 2008
- •Treated with gefitinib for at least 3 months
排除标准
- •Involvement in the planning and/or conduct of the study
- •Participation in another clinical study during the last 3 months
结局指标
主要结局
Progression-free survival
时间窗: median time from the first date of treatment until date of disease progression during Jan 2004- Dec 2008 or 5 years approx.
次要结局
- Time to maximum response(Median time from the first date of treatment until the date that the disease can be maximum controlled during Jan 2004- Dec 2008 or 5 years approx.)
- Overall survival(time from the first date of treatment until date of patients dead during Jan 2004- Dec 2008 or 5 years approx.)
- Prevalence of EGFR & KRAS mutation from laboratory result(During Jan 2004- Dec 2008 or 5 years approx.)
研究者
研究点 (1)
Loading locations...
相似试验
暂停
3 期
EGF vaccine- Advanced Lung tumorson Small Cells Lung CancerRPCEC00000161Centre of Molecular Immunology (CIM)579
已完成
不适用
Chemotherapy in Treating Patients With Lung CancerNon Small Cell Lung CancerNCT01067794Eli Lilly and Company1,610
尚未招募
不适用
Designing information for lung cancer patients in decision making.Patients presenting with a stage I non-small cell lung cancer (NSCLC).Patienten met stadium I niet kleincellige longkanker.NL-OMON2116225
Unknown
不适用
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine KinaseNon-Small-Cell Lung CancerNCT02755337Dr. Soetomo General Hospital70
已完成
不适用
Non-small Cell Lung Cancer and Quality of LifeNon Small Cell Lung CancerNCT00818402University of Turku130